$("list_view_grid_button").className = "sp-i sp-grid";
$("list_view_regular_button").className = "sp-i sp-list-view-selected";
$("image_list").update("    <div class=\"article image clearfix\">\n        <div class=\"preview\">\n          <a href=\"/se/pressroom/biogenidec_sverige_ab/image/view/tysabri-det-nya-ms-laekemedlet-9255\" class=\"material\" title=\"Tysabri - h\u00f6geffektivt l\u00e4kemedel mot MS\"><img alt=\"Tysabri - h\u00f6geffektivt l\u00e4kemedel mot MS\" src=\"http://resources0.mynewsdesk.com/files/98f80b1902ca9efc31275b5cc7ac9a39/resources/ResourceImage/small/tysabri.jpg\" /></a>\n        </div>\n    <div class=\"header\">\n        <h2><a href=\"http://www.mynewsdesk.com/se/pressroom/biogenidec_sverige_ab/image/view/tysabri-det-nya-ms-laekemedlet-9255\" title=\"Tysabri - h\u00f6geffektivt l\u00e4kemedel mot MS\">Tysabri - h\u00f6geffektivt l\u00e4kemedel mot MS</a></h2>\n    </div>\n    <div class=\"text\">\n        <p>\n            <span class=\"time\">Aug 11, 2008 10:40 CEST</span>\n            \n            Tysabri (natalizumab) \u00e4r ett h\u00f6geffektivt l\u00e4kemedel f\u00f6r behandling av multipel skleros, MS. Antalet MS-skov (perioder d\u00e5 sjukdomen f\u00f6rv\u00e4rras) minskar med tv\u00e5 tredjedelar. Behandlingen minskar kraftigt risken f\u00f6r att patienten ska f\u00e5 best\u00e5ende handikapp. \n        </p>\n    </div>\n</div>\n\n");
if ($("list_pagination")) {
$("list_pagination").update("");
}